These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23391917)

  • 41. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
    Löscher W; Fisher JE; Nau H; Hönack D
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1067-78. PubMed ID: 2506334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-dependent pharmacokinetics of toxic metabolites is not related to increased toxicity following high-dose valproic acid in rats.
    Jung BH; Kim BJ; Lee MS; Lee JH; Oh JH; Lee YJ
    J Appl Toxicol; 2010 Nov; 30(8):775-8. PubMed ID: 21157986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of dietary excess leucine on nicotinamide nucleotide level in rat liver.
    Yamada O; Shin M; Sano K; Umezawa C
    Int J Vitam Nutr Res; 1979; 49(4):376-85. PubMed ID: 233012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of feeding with a poisonous mushroom Clitocybe acromelalga on the metabolism of tryptophan-niacin in rats].
    Fukuwatari T; Sugimoto E; Shibata K
    Shokuhin Eiseigaku Zasshi; 2001 Jun; 42(3):190-6. PubMed ID: 11577392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
    Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
    J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
    Della Paschoa OE; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of dietary protein level on some key enzymes of the tryptophan-NAD pathway.
    Satyanarayana U; Rao BS
    Br J Nutr; 1977 Jul; 38(1):39-45. PubMed ID: 196615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites.
    Silva MF; Ruiter JP; IJlst L; Allers P; ten Brink HJ; Jakobs C; Duran M; Tavares de Almeida I; Wanders RJ
    Anal Biochem; 2001 Mar; 290(1):60-7. PubMed ID: 11180937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of chronic treatment with valproate and oxcarbazepine on ovarian folliculogenesis in rats.
    Cansu A; Giray SG; Serdaroglu A; Erdogan D; Coskun ZK; Korucuoglu U; Biri AA
    Epilepsia; 2008 Jul; 49(7):1192-201. PubMed ID: 18336558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
    Löscher W; Nau H
    J Pharmacol Exp Ther; 1983 Sep; 226(3):845-54. PubMed ID: 6411902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of diet restriction on some key enzymes tryptophan-NAD pathway in rats.
    Satyanarayana U; Narasinga Rao BS
    J Nutr; 1977 Dec; 107(12):2213-8. PubMed ID: 200723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes.
    Bellringer ME; Rahman K; Coleman R
    Biochem J; 1988 Jan; 249(2):513-9. PubMed ID: 3124828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in the urinary excretion of the metabolites of the tryptophan-niacin pathway during pregnancy in Japanese women and rats.
    Ftukijwatari T; Murakami M; Ohta M; Kimura N; Jin-No Y; Sasaki R; Shibata K
    J Nutr Sci Vitaminol (Tokyo); 2004 Dec; 50(6):392-8. PubMed ID: 15895513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Body niacin status in experimental diabetes mellitus; effect of protein level in the ration].
    Sadykova RE; Kodentsova VM; Dreval' AV
    Probl Endokrinol (Mosk); 1994; 40(1):41-3. PubMed ID: 8165215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid.
    Badir K; Haj-Yehia A; Vree TB; van der Kleijn E; Bialer M
    Pharm Res; 1991 Jun; 8(6):750-3. PubMed ID: 2062805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of chronic ethanol feeding on the metabolism of tryptophan and nicotinamide in rats.
    Forchette CA; Patterson JI
    J Nutr; 1983 Oct; 113(10):1936-45. PubMed ID: 6225844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histological, ultrastructural and mitochondrial oxidative phosphorylation studies in liver of rats chronically treated with oral valproic acid.
    Jimenez-Rodriguezvila M; Caro-Patón A; Dueñas-Laita A; Conde M; Coca MC; Martin-Lorente JL; Velasco A; Marañon A
    J Hepatol; 1985; 1(5):453-65. PubMed ID: 3932513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quinolinic acid metabolism; urinary excretion by the rat following tryptophan and 3-hydroxyanthranilic acid administration.
    HENDERSON LM; HIRSCH HM
    J Biol Chem; 1949 Dec; 181(2):667-75. PubMed ID: 15393784
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of excess nicotinic acid on growth and the urinary excretion of B-group vitamins and the metabolism of tryptophan in weaning rats].
    Fukuwatari T; Kurata K; Shibata K
    Shokuhin Eiseigaku Zasshi; 2009 Apr; 50(2):80-4. PubMed ID: 19436156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.